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Abstract 
 
Objective: Some cases are thought to be more complex and difficult to 
treat, although there is little consensus on how to define complexity in 
psychological care. This study proposes an actuarial, data-driven 
method of identifying complex cases based on their individual 
characteristics. 
Method: Clinical records for 1512 patients accessing low and high 
intensity psychological treatments were partitioned in 2 random 
subsamples. Prognostic indices (PI) predicting post-treatment reliable 
and clinically significant improvement (RCSI) in depression (PHQ-9) and 
anxiety (GAD-7) symptoms were estimated in one subsample using 
penalized (Lasso) regressions with optimal scaling. A PI-based algorithm 
was used to classify patients as standard (St) or complex (Cx) cases in 
the second (cross-validation) subsample. RCSI rates were compared 
between Cx cases that accessed treatments of different intensities using 
logistic regression. 
Results: St cases had significantly higher RCSI rates compared to Cx 
cases (OR = 1.81 to 2.81). Cx cases tended to attain better depression 
outcomes if they were initially assigned to high intensity (vs. low 
intensity) interventions (OR = 2.23); a similar pattern was observed for 
anxiety but the odds ratio (1.74) was not statistically significant. 
Conclusions: Complex cases could be detected early and matched to 
high intensity interventions to improve outcomes. 
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What is the public health significance of this article? 
Complex cases tend to have a poor prognosis after psychological 
treatment for depression and anxiety problems. An evidence-based 
model of defining complexity is proposed to guide therapists in 
matching patients to treatments of differing intensity. The findings 
indicate that this personalized method of treatment selection could lead 
to better outcomes for complex cases and could improve upon decisions 
that are informed by clinical judgment alone. 
 
Key words: stratified medicine; mental health; case complexity; 
psychotherapy 
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A commonly held view in clinical psychology is that complex 
cases require suitably intensive interventions guided by formulations 
that account for obstacles to improvement (Tarrier, 2006). Clinical 
wisdom reflected in treatment textbooks suggests that a variety of 
factors can complicate treatment, such as chronic symptoms, 
comorbidity, personality disorders, physical illnesses, etc. (Beck, 1998; 
Hawton, Salkovskis, Kirk, & Clark, 1989;  Tarrier, Wells, & Haddock, 
1998). Along these lines, Ruscio and Holohan (2006) proposed a list of 
more than forty factors that characterise complex cases, clustered 
around several themes including symptoms, safety, physical, 
intellectual, personality and other features. Evidently, case complexity 
is a heterogeneous concept and there is little consensus about the 
features that define such cases. 
Moreover, the empirical literature casts doubt over the predictive 
value of many variables presumed to hinder the effectiveness of therapy 
(Garfield, 1994). A case in point is found in the study by Myhr et al. 
(2007), in which only five out of ten variables thought to be indicative 
of poor suitability for cognitive therapy were (weakly) correlated with 
post-treatment outcomes. ,W LV DOVR ZHOO GRFXPHQWHG WKDW FOLQLFLDQV·
prognostic assessment of patients tends to be inaccurate (Ægisdóttir et 
al., 2006; Grove & Meehl, 1996), often failing to identify complex cases 
at risk of poor treatment outcomes (Hannan et al., 2005). In another 
study, patients randomly assigned to brief manualized interventions 
offered in a stepped care model had comparable outcomes to patients 
whose treatments were selected and informed by clinical judgment (Van 
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Straten, Tiemens, Hakkaart, Nolen, & Donker, 2006). Such evidence 
FDOOV LQWRTXHVWLRQFOLQLFLDQV·DELOLty to match patients to treatments 
and supports current guidelines to apply a stepped care approach 
(National Institute for Health and Care Excellence [NICE], 2011). 
Overall, three key problems are apparent: a lack of conceptual clarity 
about complex cases, a gap between clinical judgement and research 
evidence, and limitations in FOLQLFLDQV· DELOLW\ WR LGHQWLI\ and select 
optimal treatments for complex cases. 
Concerns regarding complexity are not exclusive to the practice 
of psychotherapy. The simultaneous growth and ageing of the general 
population have confronted many other areas of healthcare with the 
challenges of treating patients who present with multiple chronic 
conditions 6PLWK 	 2·'RZG , leading some to question the 
usefulness of evidence-based guidelines that are formulated for 
¶SURWRW\SLFDO·SDWLHQWVBoyd et al., 2005; Tinetti, Bogardus, & Agostini, 
2004). Consequently, theoretical models to account for case complexity 
in medicine have been proposed in the last decade. Some of these 
models conceptualise complexity as arising from a combination of 
clinical (e.g., diagnostic), biological, socioeconomic, cultural, 
environmental and behavioural factors that are statistically associated 
with clinical prognosis (Safford, Allison, & Kiefe, 2007; Schaink et al., 
2012). Individual patients may have protective or risk factors across 
these domains, and their overall complexity level results from the sum 
of risks. In an attempt to move beyond mere description, Shippee et al. 
(2012) proposed a cumulative complexity model which attempts to 
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explain how risk factors accumulate and interact to influence 
healthcare outcomes. They proposed that (clinical, socioeconomic, 
cultural) risk factors complicate healthcare outcomes by disrupting the 
balance between patient workload (i.e., number and difficulty of daily 
life demands including self-care) and patient capacity (i.e., resources 
and limitations affecting ability to meet demands). From this 
perspective, effective healthcare for complex cases would not only 
require intensive treatment of acute symptoms and specific disease 
mechanisms, but also attending to wider biopsychosocial aspects that 
may redress the balance between demands and capacity. Common to 
these models are the focus on empirically-supported prognostic factors, 
the consideration of factors across multiple domains, and the 
conceptual understanding of case complexity as resulting from the 
accumulation of risks and challenges to self-management. 
Informed by these theoretical models emerging from the 
biomedical sciences, this study investigated the impact of case 
complexity in routine psychological care. Considering the problems 
outlined above, we sought to assess the merits of an actuarial, data-
driven, cumulative model of defining case complexity. Specific 
objectives were: (1) to identify prognostic variables associated with 
psychological treatment outcomes; (2) to develop an algorithm that 
could aid clinicians in identifying complex cases at risk of poor 
outcomes; (3) to determine whether or not complex cases respond 
differentially to treatments of differing levels of intensity; (4) to ascertain 
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the extent to which patients are adequately matched to available 
stepped care interventions. 
 
Method 
Setting and Interventions 
This study was based on the analysis of clinical data routinely 
collected by a primary care psychological therapy service in Northern 
England. The study was approved as a service evaluation by the local 
National Health Service (NHS) Trust, which did not require formal 
ethical approval. The service offered low and high intensity 
interventions for depression and anxiety problems, as part of the 
Improving Access to Psychological Therapies (IAPT) programme (Clark et 
al., 2009). Low intensity treatments (LIT) consisted of brief (<8 sessions 
lasting 30 minutes) psychoeducational interventions based on 
principles of cognitive behavioural therapy (CBT). These were highly 
structured interventions, supported by didactic materials and delivered 
by a workforce of psychological wellbeing practitioners trained to a 
standard national curriculum (Bennett-Levy et al., 2010).  High 
intensity treatments (HIT) were lengthier (up to 20 sessions lasting 
around 60 minutes) interventions including CBT and counselling for 
depression. These interventions were also protocol-driven, delivered by 
post-graduate level counsellors and psychotherapists, following 
national treatment guidelines (NICE, 2010) and competency 
frameworks (e.g., Roth & Pilling, 2008). All therapists practiced under 
regular clinical supervision (weekly or fortnightly) to ensure ethical 
 8 
practice and treatment fidelity. These interventions were organised in a 
stepped care model (NICE, 2011), where most patients initially accessed 
a LIT and those with persistent and/or severe symptoms accessed HIT. 
Initial treatment assignment was determined by therapists who carried 
out standardised intake assessments. 
 
Measures and Data Sources 
Primary outcome measures.  Patients accessing IAPT services 
self-complete standardised outcome measures on a session-to-session 
basis to monitor response to treatment. The PHQ-9 is a nine-item 
screening tool for major depression, where each item is rated on a 0 to 
3 Likert scale, yielding a total depression severity score between 0²27 
(Kroenke, Spitzer, & Williams, 2001). A cut-RII   KDV EHHQ
recommended to detect clinically significant depression symptoms 
(Kroenke, Spitzer, & Williams, 2001), and a difference RI  SRLQWV
between assessments is indicative of reliable change (Richards & 
Borglin, 2011).  
The GAD-7 is a seven-item measure developed to screen for 
anxiety disorders (Spitzer, Kroenke, Williams, & Löwe, 2006). It is also 
rated using Likert scales, yielding a total anxiety severity score between 
0²21. A cut-RIIVFRUHLVUHFRPPHQGHGWRLGHQWLI\WKHOLNHO\SUHVHQFH
of a diagnosable anxiety disorder (Kroenke, Spitzer, Williams, Monahan, 
& Löwe, 2007), and a difference of 5 points is indicative of reliable 
change (Richards & Borglin, 2011). Pre-treatment and last observed 
PHQ-9 and GAD-7 scores were available for analysis. 
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Other measures.  The Work and Social Adjustment Scale (WSAS) 
is a measure of functioning across five domains: work, home 
management, social leisure activities, private leisure activities, family 
and close relationships (Mundt, Marks, Shear, & Greist, 2002). Each 
item is rated on a scale of 0 (no impairment) to 8 (very severe 
impairment), rendering a total functional impairment score between 0²
40. 
The Standardised Assessment of Personality ² Abbreviated Scale 
(SAPAS) is an eight-item questionnaire developed to screen for the likely 
presence of a personality disorder (Moran et al., 2003). Each question 
prompts respondents to endorse specific personality traits (yes/no), 
yielding a total score between 0²8 where a cut-off >3 is indicative of 
cases with a high probability of diagnosable personality disorders. The 
WSAS and SAPAS were gathered at the time of initial assessments. 
De-identified treatment and demographic data were also 
available, including information on referral sources, the intensity and 
sequence of treatments received (LIT and/or HIT along the stepped care 
pathway), age, gender, ethnicity and employment status. Formal 
diagnostic assessments were not carried out in routine care, but 
primary presenting problems noted in clinical records were available in 
summary form as group-level percentages. 
 
Sample Characteristics 
The study included case records for a total of 2202 patients who 
had been discharged from the service at the time of data collection. 
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Complete data (described above) were available for 1512 (68.7%) cases. 
More than half were females (63.9%), with a mean age of 41.99 (SD = 
14.54; range: 16 ² 87) and of white British ethnic background (88.2%). 
A quarter (24.9%) of all cases were unemployed and/or in receipt of 
incapacity benefits. Approximately 59.9% were referred to treatment by 
general medical practitioners; the remainder self-referred (24.3%) or 
were referred by other social and healthcare providers (15.8%). The 
presenting problems noted in clinical records were depression (21.0%), 
recurrent depression (6.6%), obsessive-compulsive disorder (4.4%), 
adjustment disorders (5.7%), somatoform disorders (0.4%), eating 
disorders (0.4%), phobic disorders (5.7%), other anxiety disorders 
(42.4%), and unspecified mental health problems (13.4%).  Mean 
baseline severity scores for the whole cohort were PHQ-9 = 14.86 (SD = 
6.33), GAD-7 = 13.27 (SD = 5.07), WSAS = 18.39 (SD = 9.46), SAPAS = 
3.82 (SD = 1.89; cases with SAPAS > 3 = 54.2%). Many patients had 
comorbid presentations, where 71.4% of cases had case-level symptoms 
in both PHQ-9 and GAD-7. Approximately 76.6% of patients were 
initially assigned to LIT and 23.4% were initially assigned to HIT. 
Overall, 40.6% only accessed LIT, 36.0% accessed LIT + HIT, and 23.4% 
only accessed HIT. Overall, 31.3% dropped out of treatment (32.2% of 
those initially assigned to LIT; 28.5% of those initially assigned to HIT). 
 
Statistical Analysis 
 Consistent with the objectives of the study, data analyses were 
performed in 4 stages aiming to develop, validate and assess the clinical 
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utility of a cumulative complexity model. The primary analyses were 
carried out in the dataset of cases with complete data (N = 1512). 
Following a cross-validation approach, we partitioned this dataset into 
two random halves which were treated as estimation (N = 755) and 
validation (N = 757) samples. In order to assess the potential influence 
of missing data, a single imputed estimation sample (N = 1108) was 
derived using an expectation-maximization method (Schafer & Olsden, 
1998) and was used for sensitivity analyses described below.  
 Stage 1 involved the development of a prognostic index and 
classification method to identify complex cases in routine care. The 
dependent variable in all models was a binary indicator of post-
treatment reliable and clinically significant improvement (RCSI), with 
separate models for depression (PHQ-9) and anxiety (GAD-7) measures. 
RCSI was determined using the criteria proposed by Jacobson and 
Truax (1991), based on combining reliable change indices for PHQ-9 
 DQG *$'-  GHVFULEHG E\ 5LFKDUGV DQG %RUJOLQ  and 
diagnostic cut-offs for each measure (PHQ-9 <10; GAD-7 <8). The 
dependent variable was coded as follows: 0 = RCSI; 1 = no RCSI, such 
that the prognostic models would be constructed to identify (more 
complex) cases with increased probability of poor outcomes.  
As an initial variable screening step, we used univariate logistic 
regressions to examine the goodness-of-fit (based on -2 log likelihood 
test and magnitude of AIC and BIC statistics) of linear and non-linear 
trends for continuous variables, as well as alternative ways to model 
the SAPAS questionnaire (as a total score, dichotomized based on a cut-
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off >3, or entered as a series of 8 binary items). Entering all 8 SAPAS 
binary items yielded the best fitting models in preliminary tests (i.e., 
lowest AIC and BIC, significant -2 log likelihood tests) and confirmed 
that only 5 items were significant (p < 0.05) predictors of outcome. 
Furthermore, baseline severity (PHQ-9, GAD-7), impairment (WSAS) 
and age variables were optimally modelled using non-linear trends. Age 
was rescaled to ordinal decade groups (e.g., teens, twenties, thirties, 
etc.) and reverse scored (oldest group coded 0, youngest group coded 6) 
based on the observed trend of correlations between age and RCSI. 
Informed by these preliminary tests, we applied penalized 
categorical regressions with optimal scaling (CATREG-Lasso) in the 
main analysis. CATREG applies classical linear regression to predictor 
variables that are transformed to categorical quantifications which are 
optimally suited to explore nonlinear relations in the data (Gifi, 1990). 
Continuous variables were thus transformed using a monotonic spline 
scaling level to examine non-linear associations with the dependent 
variable. Variable selection and regularization were performed 
combining the Lasso (Least Absolute Shrinkage and Selection Operator; 
Tibshirani, 1996) and the .632 bootstrap resampling method (Efron & 
Tibshirani, 1997). The Lasso imposes a penalty term that shrinks 
coefficients towards zero, penalizing the sum of the squared regression 
coefficients. This yields more generalizable prediction equations 
compared to conventional regression models which are prone to 
overfitting and are less reliable in the presence of multicollinearity. 
Since using different penalty terms results in different shrunken 
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coefficients, resampling techniques are often used to determine an 
optimal penalty. The .632 bootstrap resampling method is a smoothed 
version of the leave-one-out cross-validation strategy, which permits the 
HVWLPDWLRQ RI D PRGHO·V H[SHFWHG SUHGLFWLRQ HUURU This resampling 
method was applied 1000 times to each Lasso model, iteratively 
increasing the penalty term in 0.01 units, until all coefficients were 
shrunk to zero. The one-standard-error rule was applied to select the 
most parsimonious Lasso model within one standard error of the model 
with minimum expected prediction error. The predictors entered into 
CATREG-Lasso models included clinical (baseline PHQ-9, GAD-7, 
WSAS), personality (SAPAS items 1, 2, 3, 5, 7) and demographic 
variables (age groups, gender, ethnicity, employment status). Shrunken 
coefficients from the optimal models were used to calculate a prognostic 
index (PI) for each patient, where a higher PI denotes poorer prognosis. 
3,·VZHUHUHWDLQHGLQWKH&$75(*TXDQWLILFDWLRQVVFDOHwith signed and 
continuous scores centred at zero. 
The above procedure was conducted in the estimation samples 
with complete and imputed data, allowing us to compare the area under 
the curve (AUC) IRUWKH3,·VGHULYHGfrom each dataset as an indicator of 
predictive accuracy. 3,·V derived using complete and imputed samples 
had comparable AUC statistics albeit with some shrinkage observed in 
the imputed dataset (PHQ-9: 0.67 ± 0.04 vs. 0.63 ± 0.05; GAD-7: 0.74 
± 0.04 vs. 0.66 ± 0.04). Therefore, subsequent analyses were applied in 
the dataset with complete data. 
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 In stage 2, we applied receiver operating characteristic (ROC) 
curve analysis (Altman & Bland, 1994) in the estimation sample to 
determine empirical cut-offs that optimally balanced sensitivity and 
specificity on each PI. Consistent with our assumptions about clinical 
complexity, cases where both (PHQ-9 and GAD- 3,·V ZHUH DERYH
empirical cut-offs were classed as complex (Cx), and others (including 
all those with sub-clinical symptoms) were classed as standard (St) 
cases. 7KHDJUHHPHQWRIERWK3,·VZDVWDNHQDVDFRQVHUYDWLYHPHDQVRI
PLQLPLVLQJ ¶IDOVH SRVLWLYH· FODVVLILFDWLRQV, and limiting the Cx 
classification to cases with the poorest prognoses across both outcome 
domains. We then tested our assumptions about prognosis and 
cumulative complexity in the validation subsample, with cases whose 
symptoms were above diagnostic cut-offs for each outcome measure 
(PHQ-9: N = 675; GAD-7: N = 755). ROC curve analyses were used to 
DVVHVVKRZZHOOWKH3,·V(using Lasso-based shrunken coefficients from 
the estimation sample) performed out-of-sample (in a statistically 
independent validation sample). In addition, separate logistic regression 
models were applied for each outcome (PHQ-9, GAD-7), where the 
dependent variable was post-treatment RCSI status (0 = no RCSI; 1 = 
RCSI) and the predictors included case complexity (0 = Cx, 1 = St) 
controlling for baseline severity of symptoms (PHQ-9 or GAD-7 
respectively).  
 Stage 3 analyses were also conducted in the validation sample. A 
logistic regression model predicting (HIT vs. LIT) group membership 
based on all clinical and demographic characteristics was performed to 
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estimate propensity scores, denoting the predicted probability of 
completing a treatment episode at HIT. Propensity scores were entered 
as a covariate in subsequent analyses to control for confounding by 
indication. Next, logistic regression models were applied with RCSI 
status as a dependent variable, entering baseline severity (PHQ-9 or 
GAD-7 respectively), propensity scores, and treatment pathway (LIT or 
HIT only vs. LIT + HIT) as predictors. The models were performed 
separately in the subgroups of Cx (N = 269) and St (N = 425) cases (with 
available data to estimate propensity scores), to minimise 
multicollinearity between propensity scores and case complexity 
dummy variables in the same model. 
 In stage 4, we assessed the extent to which initial treatment 
assignment (LIT or HIT) determined by clinical judgement was 
consistent with the assignment that would be indicated by the 
prognostic method described above. A prognostic treatment assignment 
was coded for all patients, where starting at HIT was recommended for 
Cx cases and starting at LIT was recommended for all other cases. Next, 
agreement codes were noted IRUHDFKFDVHLQWKHIXOOVDPSOHZKHUH¶·
LQGLFDWHGDJUHHPHQWEHWZHHQFOLQLFDOMXGJPHQWDQGSURJQRVLVDQG¶·
indicated disagreement. Agreement codes were aggregated across the 
entire sample to estimate a ¶KLWUDWH·GHQRWLQJWKHSHUFHQWDJHRIFDVHV
ZKHUH FOLQLFLDQV· GHFLVLRQV FRQYHUJHG ZLWK D SURJQRVWLF VWUDWHJ\ IRU
treatment assignment. Next, we applied &RKHQ·V Kappa across 
agreement codes to derive a Treatment Matching precision (TMaP) score, 
which takes into account the probability that ¶KLWUDWHV·PD\EHGXHWR
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chance. The TMap score is therefore a robust measure of convergence 
between clinical and empirical decision-making strategies, ranging 
between 1 (perfect agreement) and ²1 (complete disagreement), where 0 
is indicative of agreement by chance. TMaP scores were estimated for 
the full sample and for individual clinicians that undertook initial 
assessments and made decisions about treatment assignment for at 
least 20 patients (to eschew extreme scores in caseloads with small base 
rates). 
 
Results 
Estimation of Prognostic Equations 
Using the CATREG-Lasso procedure in the estimation sample, we 
arrived at prognostic models that explained between 9% (PHQ-9: 
optimal scaling adjusted R2 = 0.09) and 15% (GAD-7: adj R2 = 0.15) of 
variance in post-treatment RCSI. Regression and ROC curve model 
estimates for each outcome measure are presented in Table 1 (with 
detailed outputs in supplementary appendix 1). Several predictors were 
selected into optimal Lasso models, including demographic (age, 
ethnicity, employment), personality (SAPAS items ´LQWHUSHUVRQDOO\
DYRLGDQWµ    ´VXVSLFLRXVµ    ´LPSXOVLYHµ    ´GHSHQGHQWµ), and 
clinical features (baseline PHQ-9, GAD-7, WSAS).  
The R2 share statistic reflects the relative contribution of each 
SUHGLFWRU WR WKHPRGHO·Voverall adjusted R2, after partialling out the 
specific and combined effects of the other variables. In the depression 
model, demographics had relatively greater explanatory influence 
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(22.5%) relative to personality (14.7%) and clinical features (15%), 
although the remaining R2 variance was large (47.9%) and reflected the 
combined influence of all variables in the model. In the anxiety model, 
clinical features (55.9%) had two to three times greater explanatory 
power relative to personality (23.9%) and demographic features (15.2%), 
leaving only 5% of the remaining R2 variance to combined effects. The 
F tests for specific variables in both models suggested that the removal 
of clinical factors (particularly PHQ-9) significantly deteriorated the 
predictive power of regression models. AUC statistics for the depression 
(0.67, SE = 0.02) and anxiety (0.74, SE = 0.02) prognostic indices 
applied to predict RCSI in the estimation sample were both statistically 
significant (p < 0.001); ROC curves are shown in appendix 2.  
 
[Table 1] 
 
Validation of Case Complexity Model 
3,·VXVLQJWKHshrunken coefficients derived from the estimation 
sample were applied in the validation sample, yielding stable and 
statistically significant (p < 0.001) AUC estimates for depression (0.64, 
SE = 0.02) and anxiety (0.70, SE = 0.02) measures (see ROC curves in 
appendix 2). Overall, 28.6% of all patients were classified as Cx by the 
prognostic classification rule derived using ROC curve analyses. The 
proportion of Cx cases was lower in the subsample of patients who only 
accessed LIT (15.9%) by comparison to those who accessed LIT+HIT 
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(37.3%) and those who only accessed HIT (36.7%); x2 (2) = 97.05, p < 
0.001. 
 
[Table 2] 
 
As illustrated in Figure 1, logistic regression models (Table 2) 
confirmed that St cases were significantly more likely to attain RCSI in 
depression (OR = 1.81) and anxiety (OR = 2.81) symptoms compared to 
Cx cases, after controlling for baseline severity. 
 
[Figure 1] 
 
Case Complexity and Treatment Selection 
Logistic regression models presented in Table 3 indicated that Cx 
cases had a significantly greater probability of RCSI in depression 
symptoms if they directly accessed HIT, by comparison to a standard 
stepped care pathway LIT + HIT; OR = 2.23, p = 0.01. There was also a 
trend indicating the same advantage of HIT for Cx cases in the anxiety 
model, although this did not reach statistical significance; OR = 1.74, p 
= 0.08. No significant differences were found between treatment 
pathways in the regression models applied to St cases. These analyses 
controlled for baseline symptom severity and propensity scores (derived 
from logistic regression model in appendix 3). The results for the 
depression outcomes are illustrated in Figure 2; where Cx cases that 
were initially assigned to HIT (optimal prognostic treatment assignment) 
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had a 16.3% increased probability of RCSI by comparison to Cx who 
were assigned to a conventional stepped care pathway (LIT+HIT). 
 
[Table 3] 
 
[Figure 2] 
 
Clinical judgment versus prognostic models 
The aggregated hit rate in the full sample indicated that 
FOLQLFLDQV·WUHDWPHQWDVVLJQPHQWGHFLVLRQVDJUHHGZLWKWKHSURJQRVWLF
strategy in 65.6% of cases. The TMaP score for the full sample, however, 
was low (k = 0.09, SE = 0.02, p < 0.001). A closer examination of 
individual WKHUDSLVWV·WUHDWPHQWDVVLJQPHQWGHFLVLRQV1 QHVWHG
within 26 therapists) revealed considerable variability in their hit rates 
(range = 36.5% to 84.7%, mean = 62.9, SD = 14.3) and TMaP scores 
(range = -0.27 to 0.44, mean = 0.05, SD = 0.20).  As shown in Figure 3, 
hit rates and TMaP scores were moderately correlated (r = 0.67, p < 
0.001), and approximately 48% of therapists had TMaP scores < 0. 
 
 
[Figure 3] 
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Discussion 
Main findings 
This study set out to contribute to the understanding of case 
complexity in psychological care, in view of the limited conceptual 
clarity and evidence base surrounding this topic. Our findings 
demonstrate that (1) several patient characteristics have a cumulative 
effect on treatment outcomes; (2) it is possible to make reasonably 
accurate prognoses using this information; (3) prognostic models can 
help us to operationalize case complexity in a way that is clinically 
useful. Cases classed as Cx (28.6%) on the basis of prognostic data 
tended to have significantly poorer outcomes after psychological 
treatment. Furthermore, Cx cases were two times (OR = 2.23) more 
likely to attain RCSI in depression symptoms if they were initially 
assigned to a high intensity intervention instead of usual stepped care. 
A similar trend was observed for anxiety symptoms, although this did 
not reach statistical significance. 
 
A conceptual bridge between prognosis and case complexity 
These results lend support to the clinical notion that some cases 
are more difficult to treat due to various complicating factors (Ruscio & 
Holohan, 2006), although FOLQLFLDQV·LQWXLWLRQVDQGWUHDWPHQWSODQQLQJ
are often inconsistent with the evidence base (Garb, 2005). We found 
that treatment assignment decisions guided by clinical judgment were 
consistent with prognostic models in 65.6% of cases. This rate of 
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agreement could be achieved by chance, or simply by mechanically 
following stepped care guidelines and assigning all cases initially to LIT, 
since the base rate of Cx cases is relatively low (under 30%). This was 
evidenced more clearly by examining the aggregated TMaP score (0.09) 
which was close to zero. Overall, the findings indicate that depression 
improvement (RCSI) rates for Cx cases could be significantly increased 
(by approximately 16.3%) if clinical judgment was supported by 
prognostic treatment selection models. 
This gap between practice and science is perhaps accentuated by 
an unwieldy literature on the topic of prognosis in psychological care. 
Previous authors have attempted to synthesize findings across multiple 
studies to elucidate predictors of depression and anxiety outcomes (e.g., 
Driessen & Hollon, 2010; Haby, Donnelly, Corry, & Vos, 2006; Hamilton 
& Dobson, 2002; Keeley et al., 2008; Kessler et al., 2017; Licht-Strunk 
et al., 2007; Nilsen, Eisemann, & Kvernmo, 2013). Although some 
convergent findings are evident, meta-analytic reviews that privilege 
data from clinical trials are limited by typically small samples with 
sparse and heterogeneous prognostic variables, often gathered in highly 
selected participants (i.e., those with specific disorders) that may not be 
representative of complex cases seen in routine care (Chambless & 
Ollendick, 2001). Naturalistic cohort studies can offer informative 
evidence to complement findings from controlled trials, especially where 
multiple variables are measured systematically across large healthcare 
populations, as exemplified in this study. Several such studies are 
yielding replicated findings (e.g., Beard et al., 2016; Delgadillo, Moreea, 
 22 
& Lutz, 2016; Delgadillo, Dawson, Gilbody, & Böhnke, in press; Firth, 
Barkham, Kellett, & Saxon, 2015; Goddard, Wingrove, & Moran, 2015; 
Licht-Strunk et al., 2009).  
Overall, the emerging literature on outcome prediction points to 
factors clustered around clinical (i.e., baseline symptom severity, 
diagnosis, comorbidity, functioning and disability, physical illnesses), 
demographic (i.e., age, ethnicity, employment, socioeconomic 
deprivation, marital status) characterological (i.e., personality disorder 
diagnoses or traits, interpersonal problems and style, trait anxiety and 
neuroticism) and dispositional domains (i.e., readiness to change, 
expectancy). Informed by advances in the biomedical literature (Safford 
et al., 2007; Shippee et al., 2012), we propose that complex cases in 
psychological care are characterised by the presence of measurable 
factors that map onto multiple domains (clinical, demographic, 
characterological and dispositional), which are statistically associated 
with clinical prognosis and have a cumulative ²detrimental² effect on 
treatment outcomes. The concept of case complexity is, therefore, 
dimensional (i.e., degrees of complexity on a continuum), and complex 
cases can be distinguished from others using empirically derived 
population norms and classification rules.  
Case complexity may challenge psychological improvement 
through several mechanisms. One possibility is that an accumulation 
of disadvantages (e.g., poverty, interpersonal difficulties, functional 
impairment, outgroup derogation due to minority ethnic status) could 
disrupt the balance between life stressors and coping resources 
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(Shippee et al., 2012). Complexity could also interfere with adequate 
engagement with therapy; for example by undermining expectancy, 
which is a well-established predictor of treatment outcomes 
(Constantino et al., 2011). Baseline severity is an important contributor 
to complexity, so another possibility is that high baseline severity does 
not completely block improvement but may dampen the effect of 
treatment (i.e., cases with high severity can attain reliable improvement 
even if their symptoms do not reach sub-clinical levels). Furthermore, 
our findings suggest that specific features (i.e., demographic, clinical, 
characterological) influence specific clinical outcomes (remission of 
depression, anxiety) differentially. For example, demographic factors 
(e.g., young age, unemployment) had a considerably larger influence 
over depression outcomes relative to clinical and characterological 
factors. Future research could focus on exploring the relative 
contribution of different prognostic domains to multiple outcome 
domains (symptoms, quality of life, functioning) and the mechanisms 
through which these cumulative disadvantages may complicate or 
undermine treatment. 
 
Limitations 
Some limitations should be considered when interpreting the 
results of this study. As is common in naturalistic datasets, we 
encountered several cases with missing data (>30%). To deal with this, 
we applied multiple imputation and sensitivity analyses which yielded 
similar prognostic models, albeit with some shrinkage observed in the 
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imputed dataset. On this basis, it was appropriate to perform further 
validation analyses using cases with complete data, to simulate how 
prognostic assessments would be applied in routine care, where data 
imputation of missing values is unfeasible.  
Another limitation concerning the data used in this study was 
that we only had access to pre-post outcome measures for the entire 
treatment pathway, and it was not possible to disaggregate the 
outcomes for LIT and HIT for cases that accessed both steps. However, 
we were able to determine that Cx that only accessed HIT tended to have 
better outcomes compared to those who accessed LIT + HIT (a lengthier 
and costly treatment pathway). This suggests that there are no benefits 
of having LIT sessions preceding HIT, and hence the advantage of being 
initially assigned to HIT may not be solely due to having a lengthier 
treatment episode. Previous research using more granular outcomes 
data for each treatment step suggested that cases with poor prognostic 
features had a higher probability of dropout and lower probability of 
improvement at the LIT step by comparison to HIT (Delgadillo, Moreea, 
& Lutz, 2016). These emerging findings suggest that assigning complex 
cases directly to HIT seems justified, although future randomized 
controlled trials of this strategy are necessary to determine if it is indeed 
more cost-effective. 
Other limitations include the lack of formal diagnostic 
assessments and the analysis of a limited number of prognostic 
variables. It is known, for example, that specific diagnoses such as post-
traumatic stress disorder, eating disorders and obsessive-compulsive 
 25 
disorder are associated with poorer outcomes in stepped care services 
(Delgadillo, Dawson, Gilbody, & Böhnke, in press), and it is plausible 
that such diagnoses could interact with other prognostic features. 
Notwithstanding these limitations, it is remarkable that this narrow 
range of variables yielded an accurate and clinically useful prognostic 
model. Other studies using routine practice data have shown that 
similar variables can be used to identify subgroups of cases with 
depression and anxiety problems that attain similar outcomes 
(Delgadillo, Moreea, & Lutz, 2016; Lutz, Lowry, Kopta, Einstein, & 
Howard, 2001; Lutz et al., 2005; Saunders, Cape, Fearon, & Pilling, 
2016). 
 
Clinical implications 
In line with recent findings in stepped-care psychological 
treatment settings (Delgadillo, Moreea, & Lutz, 2016; Lorenzo-Luaces, 
DeRubeis, van Straten, & Tiemens, 2017), the present study provides 
further evidence that applying prognostic indices to guide personalized 
treatment recommendations is likely to improve treatment outcomes. 
Low intensity guided self-help interventions are recommended as first-
line treatments for several common mental disorders (NICE, 2011) and 
are becoming widely available in routine stepped care services (Clark, 
2011). The application of evidence-based treatment selection 
algorithms like the one demonstrated in this study could help to 
maximise the cost-effectiveness of LIT by selectively offering it to those 
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who are most likely to derive benefits. Equally, prognostic models could 
be used to fast-track complex cases to HIT in a timely way. 
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Table 1. Estimation of prognostic indices using penalized categorical regression with optimal scaling 
 
 
 
Depression (PHQ-9) model parameters  Anxiety (GAD-7) model parameters 
 F(591) = 4.13, p < 0.001 
Adjusted R2 = 0.09 
AUC = 0.67, SE = 0.02 (0.64, 0.71), p < 0.001 
 F(643) = 6.85, p < 0.001 
Adjusted R2 = 0.15 
AUC = 0.74, SE = 0.02 (0.70, 0.78) , p < 0.001 
 Lasso-based coefficients  Lasso-based coefficients 
   importance    importance 
Predictors B SE R2 share removal 
impact 
 
B SE R2 share removal 
impact 
Gender 0.000 0.002    0.000 0.007   
Ethnicity 0.000 0.009    0.007* 0.023 3.9% p = 0.77 
Age group 0.019* 0.028 8.8% p = 0.72  0.022* 0.030 4.4% p = 0.65 
Employment 0.065* 0.037 13.7% p = 0.08  0.067* 0.038 6.9% p = 0.07 
SAPAS item 1 0.000 0.026    0.000 0.015   
SAPAS item 2 0.050* 0.037 9.4% p = 0.18  0.072* 0.040 7.3% p = 0.08 
SAPAS item 3 0.016* 0.025 1.7% p = 0.52  0.052* 0.036 4.1% p = 0.15 
SAPAS item 5 0.000 0.019    0.056* 0.034 9.8% p = 0.11 
SAPAS item 7 0.007* 0.024 3.6% p = 0.77  0.006* 0.023 2.7% p = 0.79 
Baseline PHQ-9 0.085* 0.040 9.0% p < 0.01  0.138* 0.038 19.0% p < 0.001 
Baseline GAD-7 0.034* 0.035 6.0% p = 0.39  -0.094* 0.041 30.8% p = 0.02 
Baseline WSAS 0.000 0.023    0.057* 0.037 6.1% p = 0.07 
Notes: Dependent variables in both models are categorical markers for post-treatment remission of symptoms (0 = remission; 1 = no remission); AUC = area under the 
curve statistic; Beta coefficients are expressed in a categorical quantification scale; * predictors selected into optimal Lasso model; SE = standard errors aggregated 
over 1000 bootstrap samples; R2 share = squared partial correlation between predictor and outcome / adjusted R2; removal impact = F test probability of model 
deterioration if the predictor is removed; Gender: female = 0, male =1; Ethnicity: white British = 0, minority ethnic group = 1; Employment: employed = 0, unemployed = 
6$3$6LWHPQRWHQGRUVHG LWHPHQGRUVHG D³QR´DQVZHUWRLWHPLVUHYHUVHVFRUHG  
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Table 2. Validation of prognostic indices applied out-of-sample using logistic regression  
 
 
 
Depression (PHQ-9) model parameters  Anxiety (GAD-7) model parameters 
 Nagelkerke R2 = 0.08  Nagelkerke R2 = 0.08 
Predictors B SE OR (95% CI) 
 
B SE OR (95% CI) 
Baseline VHYHULW\ -0.06** 0.02 0.94 0.90, 0.98  -0.001 0.02 0.99 0.96, 1.04 
Case complexity 0.59** 0.20 1.81 1.21, 2.69  1.03*** 0.18 2.81 1.98, 3.98 
Constant 0.57 0.46 1.77   -0.70 0.40 0.50  
Notes: Dependent variables in both models are categorical markers for post-treatment remission of symptoms (0 = no remission; 1 = remission); ** p < 0.01; *** p < 
6( VWDQGDUGHUURUWKHEDVHOLQHVHYHULW\PHDVXUHHLWKHU3+4-9 or GAD-7) entered in each model matched the relevant outcome variable; Case complexity: 
Cx = 0, St =1 
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Table 3. Logistic regression models assessing case complexity and treatment selection  
 
 
 
Depression (PHQ-9) model parameters  Anxiety (GAD-7) model parameters 
Predictors B SE OR (95% CI) 
 
B SE OR (95% CI) 
Subsample of Cx cases Nagelkerke R2 = 0.11               Nagelkerke R2 = 0.10 
%DVHOLQHVHYHULW\ -0.10** 0.03 0.90 0.84, 0.97  -0.05 0.04 0.95 0.88, 1.03 
Propensity score -3.28* 1.27 0.04 0.003, 0.46  -4.70*** 1.29 0.01 0.001, 0.11 
Treatment = LIT+HIT (ref)          
Treatment = LIT -0.02 0.34 0.98 0.50, 1.92  0.13 0.34 1.14 0.58, 2.21 
Treatment = HIT 0.80* 0.31 2.23 1.21, 4.13  0.55 0.32 1.74 0.93, 3.25 
Constant 3.67** 1.23 39.29   3.46** 1.17 31.77  
Subsample of St cases Nagelkerke R2 = 0.01               Nagelkerke R2 = 0.06 
%DVHOLQHVHYHULW\ -0.03 0.03 0.97 0.91, 1.03  0.05 0.03 1.05 0.98, 1.11 
Propensity score -0.51 0.98 0.60 0.09, 4.06  -3.69*** 0.92 0.03 0.004, 0.15 
Treatment = LIT+HIT (ref)          
Treatment = LIT -0.14 0.25 0.87 0.53, 1.43  -0.18 0.24 0.83 0.52, 1.34 
Treatment = HIT 0.32 0.34 1.38 0.70, 2.70  0.00 0.32 1.00 0.54, 1.86 
Constant 1.03 0.71 2.79   1.81** 0.66 6.13  
Notes: Dependent variables in both models are categorical markers for post-treatment remission of symptoms (0 = no remission; 1 = remission); * p < 0.05; ** p < 0.01; 
*** p 6( VWDQGDUGHUURUWKHEDVHOLQHVHYHULW\PHDVXUHHLWKHU3+4-9 or GAD-7) entered in each model matched the relevant outcome variable; OR = odds 
ratios and 95% confidence intervals; Cx = complex cases; St = standard cases; ref = reference category 
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Figure 1. Reliable and clinically significant improvement (RCSI) in cases classified as standard (St) and complex (Cx) 
 
                 Panel A: Depression (PHQ-9)                                                      Panel B: Anxiety (GAD-7) 
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Figure 2. Reliable and clinically significant improvement (RCSI) in cases classified as standard (St) and complex (Cx) 
according to treatment pathway 
 
 
Odds Ratio = 2.23 
(95% CI = 1.21, 4.13) 
p < .05 
p > .05 
n=206    n=135    n=65 n=63       n=131    n=75 
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Figure 3. Distribution of hit rates and treatment matching precision (TMaP) scores across 26 therapists 
 
 
